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Mitochondrial DNA deletion: A cause of chronic tubulointerstitial
nepbropathy. We report the first case of a mitochondrial DNA (mtDNA)
deletion diagnosed by renal biopsy. An eight-year-old girl with mega-
loblastic anemia and severe growth retardation developed progressive
renal insufficiency accompanied by partial Fanconi syndrome. Histo-
logic examination of the renal biopsy disclosed nonspecific chronic
tubulointerstitial disease characterized by tubular atrophy and intersti-
tial fibrosis. On ultrastructural examination, tubular cell mitochondria
were extremely dysmorphic with prominent size variation, abnormal
arborization, disorientation of the cristae and osmiophilic electron-
dense inclusions. Functional histochemical stains for mitochondrial
enzymes performed on cryostat renal sections revealed focal tubular
absence of cytochrome C oxidase (COX), a respiratory chain enzyme
partially encoded by mtDNA, with preservation of succinate dehydro-
genase (SDH), a respiratory chain enzyme entirely encoded by nuclear
DNA (nDNA). Immunoreactivity for COX subunit 2 (encoded by
mtDNA) was weak to undetectable in most tubular cells, whereas
reactivity for subunit 4 (encoded by nDNA) was intense in all cells.
Molecular analysis of the mtDNA of kidney and peripheral blood
leukocytes was performed using Southern blot and PCR. Both tech-
niques disclosed a 2.7 kb mtDNA deletion located between nucleotide
(nt) 9700 and nt 13700, a common site for mtDNA deletions associated
with encephalomyopathies. Mitochondrial DNA deletions may be an
under-recognized cause of idiopathic tubulointerstitial nephropathy in
children lacking neurologic or myopathic manifestations.
Mitochondria are the only subcellular organdies equipped
with their own DNA (mtDNA). The 16.5 kb, circular, double
stranded mtDNA encodes 13 structural proteins, all of which
are members of the respiratory chain complexes; only complex
II (succinate dehydrogenase) is entirely encoded by nuclear
DNA (nDNA) [1, 2]. MtDNA also encodes 22 tRNAs and the
12s and 16s rRNAs comprising the small and large subunit of
mitochondrial ribosomes, which are required for intramitochon-
dna! protein synthesis. MtDNA is transcribed polycistronicaily
and further enzymatically processed into mature messenger
RNAs (mRNAs). At least one of these transcription factors
(mtTF-l) [1] is encoded by nDNA. Furthermore, nDNA en-
codes most of the mitochondrial structural proteins as well as
enzymes involved in mtDNA replication and repair [2, 3].
Obviously, dysfunction of such nDNA encoded proteins may
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cause defects of the mtDNA. Thus, mutations of nDNA,
mtDNA, or both, may constitute the genetic basis of snitochon-
drial diseases.
Mitochondrial diseases have heterogeneous clinical pheno-
types [4]. Organ systems most commonly involved are the
central nervous system, skeletal muscles, cardiac conduction
system, hematopoietic system and pancreas [5, 6], whereas
liver, endocrine system and kidney [7—9] are affected infre-
quently and usually late in the course of the disease. MtDNA
deletions have been found in patients with Pearson syndrome
[10], a disorder manifesting in infancy and characterized by
refractory sideroblastic anemia, thrombocytopenia, neutrope-
nia, pancreatic insufficiency, renal tubulopathy and hepatic
dysfunction accompanied by lactic acidosis [5, 8, 11]. Certain
forms of mitochondnal encephalomyopathies are also associ-
ated with mtDNA deletions [12—14]. Al! of them exhibit pro-
gressive external ophthalmoplegia, either alone or as part of the
multisystem Kearns-Sayre syndrome (KSS), which also in-
cludes pigmentary retinopathy and one of the following: heart-
block, cerebellar dysfunction or elevated CSF protein level
(>100 mg/dl) [2]. Renal manifestations are infrequent in KSS
[15]. Our patient presented with anemia and renal disease and
only later developed external ophthalmoplegia. Ultrastructural,
histochemical, and immunohistochemical analysis of renal tis-
sue obtained by percutaneus renal biopsy indicated a mitochon-
drial disorder, which was confirmed by molecular genetic
analysis showing a mtDNA deletion.
Case report
This nine-year-old girl was the 2.9 kg product of a 37 week
gestation, born to non-consanguineous parents with no family
history of genetic disorders. Her 18-year-old brother is alive
and well. Her pre- and pen-natal history were unremarkable. At
the age of three years she developed megaloblastic anemia (Hct
= 30%, Hb = 8.6 gldl, MCV = 97 fi, Reticulocytes = 2.1%,
WBC = 5.5 X 109/liter, PIt = 178 x 109/liter). Further labora-
tory work-up was undertaken and normal results were obtained
for serum concentrations of: folate, bilirubin (direct, indirect,
and total), LDH, uric acid, amylase, T3, T4, TSH, Fe, TIBC,
ferritin, and free erythrocyte protoporphyrin. Serum B-12 con-
centration was found to be elevated at 1600 mg/dl (nl. = 200 to
950). Normal or negative results were also obtained from
Hamm's test and sucrose gradient RBC incubation, hemoglobin
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electrophoresis, quantitative I-IbF, direct Coomb's test, anti-
nuclear antibody, and HIV antibody. Studies of di-epoxy bu-
tane chromosome fragility gave normal results. Serum concen-
trations of BUN (=10 mg/dl), and creatinine (=0.5 mg/dl) were
normal. Abdominal ultrasound demonstrated large kidneys and
a very echogenic pancreas. A bone marrow aspirate displayed
normal cellularity with a 3 to 1 ratio of myeloid to erythroid
precursors and an adequate number of megakaryocytes. Cyto-
plasmic vacuolization of myeloid and erythroid precursors was
noted. By the age of five years, her growth parameters dropped
from the 50th to the 10th percentile for height and from the 10th
to the 5th percentile for weight.
At the age of seven years, urinalysis disclosed 2+ proteinuria
without formed elements. Serum creatinine was elevated at 0.9
mg/dl (estimated GFR = 71.5 ml/min./i.73 m2). By the follow-
ing year she had developed renal glycosuria (blood glucose = 97
mg/dl). A further rise of her serum creatinine to 1.6 mgldl
prompted referral to a pediatric nephrologist. At that time,
other laboratory results were notable for a markedly elevated
urine protein/urine creatinine ratio of 9.4. Serum albumin and
cholesterol concentrations were normal. In addition, she had
developed a metabolic acidosis (plasma HC03 17 mmol/
liter), hyperkalemia (plasma K 5.8 mmol/liter), hypophos-
phatemia (serum phosphate 3.4 mg/dI) with a high fractional
excretion of phosphate of 28% (expected value = 15 to 20% for
a patient of comparable age and diet, with a normal serum
phosphate concentration) and normal values for serum Ca
(=9.1 mg/dl) and intact PTH (=36 pg/ml; nI. = 10 to 65 pg/ml).
Alkaline phosphatase was mildly elevated at 408 U/liter. Uri-
nary acidifying capacity seemed preserved with a urine pH of
5.5 at a time when plasma HC03 was 21 mmol/liter. Calcula-
tion of the trans-tubular potassium gradient (TTKG = urinary
K x plasma osmolarity/plasma K x urine osmolarity [16]) on
two occasions gave values of 0.57 and 1.0. Concomitant respec-
tive values for fractional excretion of sodium of 10.5% and
13.6% documented adequate distal delivery of sodium. Rod-
riguez-Soriano, Ubetagoyena and Vallo [17] demonstrated that
in children with adequate distal sodium delivery a TTKG value
below 4.1 is consistent with the diagnosis of decreased aldoste-
rone effect on distal tubular segments. Thus, in our patient the
hyperkalemia was likely the result of decreased action of
aldosterone on the distal and cortical collecting tubules. That
this decreased action of aldosterone was due to tubular insen-
sitivity to the hormone rather than to aidosterone deficiency
was suggested by the measurement of a normal aldosterone
concentration of 4.0 ng/dl (normal = 4 to 31 ng/dl) at a time
when her serum potassium concentration was being maintained
in a normal range by use of sodium polystyrene sulfonate and
her blood pressure was being controlled with lisinopril. Urine
output was maintained at 1000 to 1200 mi/day. Sodium bicar-
bonate (975 mg tid) and calcitriol (0.25 pg qod) were begun and
successfully corrected the metabolic abnormalities resulting
from her chronic renal insufficiency.
Due to the patient's progressive, non-oliguric renal insuffi-
ciency associated with heavy proteinuria and tubular defects in
phosphate and glucose reabsorption, a percutaneous renal
biopsy was performed. After the biopsy diagnosis, additional
treatment was implemented (Coenzyme Q60 mg tid, vitamin C
250 mg tid, folic acid 1 mg tid, Carnitine 500 mg tid, vitamin E
400 mg qd). In addition, an attempt was made to reduce renal
tubular energy expenditure by adding NaCI 1 gm tid. The salt
therapy had to be discontinued due to the development of
edema and hypertension. No neurologic symptoms were evi-
dent at the time of renal biopsy. Over the ensuing year the
patient developed decreased mobility of extraocular muscles
and bilateral ptosis of the eyelids. Eye movements improved
slightly after therapy was initiated. A 24-hour EKG recording
was normal. Over the 20 months since the biopsy, her renal
function has continued to deteriorate (most recent creatinine =
3.7 mg/dl) and she has developed hypertension requiring treat-
ment with lisinopril and nifedipine.
Methods
The renal biopsy was divided in three pieces. The first was
snap-frozen in 2-methyl butane (—80°C), the second was fixed
in cacodylate buffered glutaraldehyde and processed for elec-
tronmicroscopy, and the third was fixed in Bouin's fixative and
processed for routine histology.
Histochemical and immunohistochemical analysis was car-
ried out on frozen renal tissue. A case of chronic tubulointer-
stitial nephritis served as control. Six-micrometer thick cryostat
sections were stained for cytochrome c oxidase (COX) and
succinate dehydrogenase (SDH) by adding the corresponding
substrates (cytochrome c and succinate) together with the
chromogens diaminobenzidine (for COX) and nitroblue-tetra-
zolium (for SDH) [13]. COX (complex IV) is encoded by both
mtDNA and nDNA; SDH (complex II) is encoded entirely by
nDNA. To evaluate whether lack of COX function was due to
absence of mtDNA or nDNA encoded portions of the complex
IV (COX), frozen sections were stained with antibodies to
subunits 2 (mtDNA) and 4 (nDNA) of COX using an indirect
immunofluorescence technique [13].
Total DNA for Southern blot and PCR analysis was obtained
from frozen renal tissue and peripheral blood leukocytes.
Normal leukocytes were used as control.
Southern blot analysis
Five micrograms of total DNA were digested with PvuII. The
restriction fragments were separated by electrophoresis on a
0.8% agarose gel and subsequently hybridized with a
labeled probe composed of the entire mitochondrial genome [6].
Since PvuII cuts mtDNA at only one site, wild type mtDNA
migrates as a single 16.5 kb band. When a deletion of mtDNA is
present, a second band representing the smaller mutant mtDNA
is observed. By comparing the migration of these fragments
with fragments of known size run concurrently, the approxi-
mate size of the deleted DNA fragment can be calculated.
PCR analysis
Four different oligonucleotide primers were used to deter-
mine the approximate region of the mtDNA deletion within the
mtDNA genome [181. One set of primers, the forward primer
(F) binding to nucleotides (nt) 8.274-8.305 and the backward
primer (B) hybridizing to nt positions 13.720-13.692, flanks the
4.9 kb region which is frequently deleted in patients with
Kearns-Sayre syndrome ("common deletion"). The other two
primers hybridize to nucleotide positions 9.744-9.765 F and
12.653-12.629 B. The conditions for the PCR have been de-
scribed elsewhere [181.
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Fig. 1. PAS stain (A) of renal biopsy showing
stripe-like tubular atrophy of the nzedullary
rays. Most atrophic tubules contain PAS
positive fibrillar casts (arrows) consistent with
Tamm-Horsfall protein (THP) (x 100).
Masson's trichrome stain (B) demonstrates
THP in Bowman's space (arrow) consistent
with tubular reflux (X400).
Results
Histological findings
Approximately half of the glomeruli showed irregular retrac-
tion of the tuft with dilation of Bowman's space. There was
chronic tubulointerstitial disease characterized by stripe-like
moderate to severe tubular atrophy involving the medullary
rays, associated with interstitial fibrosis (Fig. 1). Most of the
atrophic tubules contained strongly PAS positive fibrillar casts
suggestive of Tamm-Horsfall protein (Fig. 1). Similar casts
were also observed in the medullary collecting tubules and
infrequently in Bowman's space (Fig. 1). Routine immunofluo-
rescence studies for immunoglobulin and complement were
negative.
Ultrastructural findings
On ultrastructural examination proximal tubules displayed
abnormalities in mitochondrial number, size and configuration
(Fig. 2). Mitochondria were increased in number and showed
prominent variation in size associated with abnormal arboriza-
tion and disorientation of mitochondrial cristae including circu-
lar and parallel stack arrangements. Some mitochondria con-
tained electron dense granular and fibrillar inclusions (Fig. 2).
Other subcellular organelles and the tubular brush border
appeared normal.
Histochemical and immunohistochemical findings
Atrophic tubules showed no reactivity for COX (brown
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Fig. 2. Electronmicrographs showing
abnormal arborization and disorientation of
mitochondrial cristae (A xl 1700) and electron
dense miwchondrial inclusions (B, X10800).
strongly reactive in all tubules (Fig. 3). The control sample from
a patient with chronic drug-induced tubulointerstitial nephritis
displayed diffuse positivity for both enzymes in atrophic and
non-atrophic tubules. Since SDH is solely encoded by nDNA
and COX is partially encoded by mtDNA (subunits 1 to 3), the
selective absence of COX reactivity in our case pointed to a
defect of the mtDNA. This assumption was corroborated by the
fact that immunostaining was markedly reduced for the mtDNA
encoded subunit 2 of COX (Fig. 4) and normal for the nDNA
encoded subunit 4 of COX (Fig. 4). Control samples stained
positive with both antisera.
Southern blot analysis
Southern blot hybridization performed on PvuII digested
total DNA obtained from both renal tissue and peripheral blood
leukocytes demonstrated an identical deletion of mtDNA. The
16.5 kb band, corresponding to the wild type mtDNA, was seen
in all the control and patient samples. However, samples from
the patient also displayed an additional band at approximately
13.7 kb, representing mtDNA with a deletion of 2.8 kb (Fig. 5).
Peripheral blood leukocytes contained approximately 50% de-
leted mtDNA, whereas approximately 90% renal tubular cell
mtDNA was deleted.
PCR analysis
Using PCR the approximate location of the 2.8 kb deletion
was determined. Amplification with primers binding to nt
8.274-8.305 F and 13.720-13.692 B (Fig. 6, lane 1) and 9.744-
9.765 F and 13.720-13.692 B (Fig. 6, lane 2) yielded PCR
products of 2.7 kb and 1.3. kb, respectively, which are roughly
2.8 kb shorter than the expected sizes of 5.5 kb and 4.1 kb
obtained for wild type mtDNA. The 5.5 kb and 4.1 kb band
representing wild type mtDNA are absent in lanes 1 and 2,
despite the presence of roughly 50% wild type DNA in blood
leukocytes, because the PCR parameters (length of extension)
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The deleted segment was localized between nucleotide position
9.765 and 13.692, because the primers 9.744-9.765 F and 13.720-
13.692 B (Fig. 6, lane 3) hybridized to the mutated mtDNA,
whereas PCR amplification using primer 12.653-12.629 B
showed only amplification of wild type mtDNA represented by
the 4.4 kb band in lane 3 of Figure 6. The absence of PCR
product from mutated mtDNA using primer 12.653-12.629 B
indicates that this mtDNA segment is part of the 2.8 kb
deletion.
Discussion
This case represents the first example of a mtDNA deletion
diagnosed by renal biopsy. The patient reported herein had
been followed for refractory megaloblastic anemia and growth
retardation for several years before the development of partial
Fanconi syndrome and progressive deterioration of renal func-
tion. Mild external ophthalmoplegia with ptosis of the eyelids
occurred only after the diagnosis of a mitochondrial disorder
Fig. 3. COX (A, B) and SDH (C, D)
histochemistry of renal tubular cells. COX
reactivity of the patient's biopsy (A) is
markedly reduced compared to the control
(B). SDH staining appears equally intense for
the patient's biopsy (C) and the control
specimen (D) (x 400).
associated with mtDNA deletion had been made by percutane-
ous renal biopsy. Refractory anemia and progressive external
ophthalmoplegia are features of Pearson syndrome and Kearns-
Sayre syndrome (KSS), respectively. MtDNA deletions are
invariably present in both syndromes [5, 6]. As in our patient,
features of each of these clinical syndromes may co-develop in
the same patient [19]. Reportedly, survivors of Pearson syn-
drome may develop KSS later in life. Although Pearson syn-
drome is frequently associated with renal involvement [8, 11,
19], the clinical picture of our patient is unusual for the severe
degree of renal insufficiency, whereas the anemia was compar-
atively mild. It was this disproportionately severe renal involve-
ment that caused her to come to the attention of a nephrologist,
and ultimately led to the renal biopsy diagnosis of a mtDNA
deletion.
The wide spectrum of clinical manifestations of mitochon-
drial disorders is related to specific features of mtDNA genetics
which are different from nDNA genetics [2, 20]. Most cells,
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Fig. 3. Continued
including the oocytes, contain thousands of copies of mtDNA
with approximately 10 to 12 copies of mtDNA present in each
mitochondrion. Only a fraction of mtDNA carries the respec-
tive mutations. This leads to coexistence of mutated and wild
type mtDNA in the same cell, a phenomenon known as hetero-
plasmy [2, 21]. Since all mitochondna derive from the oocyte,
mtDNA mutations are usually maternally inherited, an inheri-
tance pattern different from Mendelian genetics [20]. Mendelian
rules, however, are applicable to mitochondrial diseases caused
by deficiencies of nDNA encoded mitochondrial proteins.
MtDNA deletions are usually sporadic, as in our case. Suppos-
edly, the event leading to mtDNA deletion occurs early in
development, because mtDNA deletions co-exist in many organ
systems. Only selected organ systems, however, show clini-
cally significant dysfunction [4, 21]. Since mutated mtDNA is
randomly distributed to daughter cells during mitosis, different
cells may contain varying ratios of mutated versus wild type
mtDNA (for example, heteroplasmy), explaining the clinical
heterogeneity [15]. Two factors related to heteroplasmy ac-
count for clinically evident organ dysfunction. First, a threshold
number of mutant mtDNA must be present for the disease to be
expressed in a given tissue. Second, the threshold may vary in
different tissues according to the dependence of each tissue on
oxidative metabolism [2].
Our patient exhibited approximately 90% deleted mtDNA in
renal tubular cells, whereas blood leukocytes contained approx-
imately equal ratios of deleted and wild type DNA, thereby
accounting for the dominance of renal symptoms. Such a large
percentage of mutated mitochondria in renal tissue has not been
reported previously. Interestingly, the structure most severely
affected in our case was the medullary ray, which comprises the
straight portions (predominantly S3 segment) of the proximal
tubules as well as the cortical collecting tubules and the thick
ascending limb of Henle. This was evidenced by the stripe-like
fibrosis and presence of numerous casts containing Tamm-
Horsfall protein. This portion of the nephron is particularly
vulnerable to limited oxygen availability [221. Similar histologic
findings are observed with chronic cyclosporin toxicity [23]
which is associated with renal ischemia [221.
It has been suggested that tissues with a high mitotic rate,
such as hematopoietic cells, are able to select against hetero-
plasmic cells in the course of continued cell division [19, 21].
This phenomenon can lead to spontaneous resolution of anemia
in older patients with long-standing Pearson syndrome. Con-
versely, the ratio of deleted mitochondrial genomes increases
with age in permanent tissues such as muscle and brain ac-
counting for the usually late onset of progressive neuromuscu-
lar symptoms [24]. Since renal tubular cells have a high regen-
erative potential, renal symptoms may only be present in the
early stages of mitochondrial diseases and resolve spontane-
Fig. 5. Southern blot of total DNA extracted from normal control
leukocytes (lane 1) and control renal tubular cells (lane 3), the patient's
leukocytes (lane 2) and patient's kidney (lane 4). Five micrograms of
DNA were digested with PvuII and hybridized with P32 labeled
mtDNA. Samples of the patient (lanes 2 and 4) disclosed an additional
band at 13.7 kb representing the deleted mtDNA.
disorders may be under-recognized in patients coming to clini-
cal attention late in the course of their disease. In our case the
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Fig. 4. Immunofluorescence staining for COX
subunits 2 (A) and 4 (B). Renal tubular
epithelial cells stain faintly for mtDNA
encoded COX subunit 2, whereas staining for
nDNA encoded subunit 4 is strongly reactive.
The faint reactivity for COX subunit 2 in the
patient's renal tubular cells is due to the







ously. Therefore, clinical renal involvement in mitochondrial severity of renal involvement necessitated a renal biopsy and
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The 2.8 kb mtDNA deletion observed in our patient is one of
the shortest reported so far and does not involve any of the
structural genes encoding subunits of COX. Nevertheless,
histochemical and immunohistochemical stains revealed a
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